Proteins localize, assemble, and function within distinct subcellular neighborhoods. Their biological meaning comes not only from their presence, but from where they operate within the cell and how those local interactions evolve under perturbation. Diseases occur when proteins malfunction accompanied with abnormal protein localization. Knowing where the protein workers are in and outside of the complex cell factory has long been a strong interest among biological scientists.
For decades, proteomics has delivered extraordinary depth, but it has remained largely challenging to know localized proteomes, i.e. where region-specific proteins reside. Meanwhile, in situ and antibody-based imaging have illuminated cell architecture and hinted at molecular interactions, yet often at the cost of unbiased discovery, proteomic breadth, or nanoscale precision. For example, we still only have limited knowledge about the protein composition of the micron-scale Lewy bodies of Parkinson’s disease.
To truly understand biology, we must connect molecular identity with spatial geography. Biology happens in space: organelles communicate, signaling complexes assemble, and protein networks operate within nanoscale domains that define cell function and fate.
Beyond Optical Limits: Refining Optical Precision with Chemistry
Syncell’s Microscoop® Mint enables in situ proteomic discovery by automated microscopy-guided photobiotinylation on regions of interest (ROIs). Two-photon illumination triggers a photochemical reaction of the Synlight-Rich™ reagent so that proteins at the ROIs are biotinylated and later pulled down for proteomic analysis using LC/MS-MS. The labeling precision is determined by the energy enough for the photochemical reaction, related to the optical resolution or diffraction limit of microscopy. Subcellular proteomic discovery thus becomes feasible.
When the ROIs are even smaller such as critical subcellular architectures of synaptic nanoclusters, mitochondrial contact zones, endosomal interfaces, or vesicle fusion points, or when the interactome is of interest, the labeling precision using Synlight-Rich becomes challenging.
Synlight-Pure™ opens an entirely new experimental dimension that moves largely beyond the limitations of light and optics. The result is the ability to probe molecular environments at a level of detail once thought inaccessible down to 25nm precision, revealing the intricate proteomic organization and interactions. Synlight-Pure contains an antibody-conjugated photosensitizer, so when the two-photon illumination is applied to the ROI, the reaction species can only travel a limited diffusion distance, resulting in double confinement of microscopy-based spatial selection and chemistry-based reactivity radius. Now nanoscopic proteomic discovery becomes feasible.
Synlight Enables Spatial Precision in Every Context
Spatial precision transforms discovery across every biological context from cultured cells to complex tissues.
In cell culture systems, subcellular proteomic discovery allows researchers to:
- Quantify localized signaling events, such as receptor activation zones or cytoskeletal remodeling fronts.
- Identify drug-responsive microdomains through surfaceome analysis, pinpointing compound engagement or off-target binding.
- Reveal protein constituents in organelle or sub-organelle ROIs important for understanding cellular functions or deciphering disease mechanisms.
In structured tissues such as tumors, brain, or organoids, microscopy-guided proteomics adds an orientational layer within architecture. It reveals how distinct cell populations interact, how gradients of signaling proteins define functional boundaries, and how disease remodels proteomic landscapes across interfaces—tumor–stroma, neuron–glia, or immune–tumor junctions.
From Mechanism to Medicine: Precision Fuels Discovery
For translational and pharmaceutical scientists, these insights are profound. Most therapeutic targets act locally within receptor microdomains, synaptic nanoclusters, or vesicular networks.
These nanoscale domains, not bulk compartments, are where biology and drug action intersect. Capturing their proteomic identity in such high precision is essential for identifying druggable vulnerabilities and spatially resolved biomarkers.
Syncell’s Microscoop integrates microscopy-based control with precision photolabeling, creating a discovery-driven, semi-quantitative bridge between imaging and proteomics. Scientists can now define the proteome of a specific subcellular or microanatomical feature such as a synapse, capillary niche, or adhesion zone and track how it changes in response to drugs or disease.
This capability turns exploratory studies into hypothesis-generating pipelines for new targets, biomarkers, and mechanistic insight.
Two Complementary Windows into Biology: Synlight-Rich and Synlight-Pure
Syncell’s microscopy-guided proteomics ecosystem features two complementary photolabeling reagents, Synlight-Rich and Synlight-Pure, each optimized for a different layer of discovery.
Synlight-Rich™ : Broad Discovery with High Sensitivity
Synlight-Rich™ is designed for exploratory, unbiased discovery of unknown proteomic landscapes. Using two-photon photo-biotinylation, it labels proteins within a user-defined microscopy region of interest at ~350 nm precision. This broad labeling captures the complete proteomic composition of a region such as a synapse, junction, or organelle revealing which proteins localize, co-reside, or respond under perturbation.
Synlight-Rich™ excels in:
- Comprehensive surfaceome or subcellular profiling.
- Comparing proteomic changes under stress, differentiation, or drug treatment.
- Building an atlas of subcellular proteome distributions.
It is the optimal tool for first-pass discovery, where sensitivity and completeness are key.
Synlight-Pure™ : Focused Precision with Molecular Specificity
Synlight-Pure builds upon this foundation to deliver nanoscopic selectivity. By combining antibody-mediated proximity labeling with Microscoop’s spatially controlled illumination, Synlight-Pure confines labeling to ~25 nm precision around a specific target or complex. This dual confinement, image-based and chemistry-based, isolates only those interactors residing in the immediate nanoscale neighborhood of the target.
Synlight-Pure™ enables:
- Targeted interrogation of receptor complexes and interactomes.
- Isolation of nanoclusters, transport intermediates, or signaling hubs.
- Validation of candidate proteins in highly specific contexts.
The result is a molecular zoom: a view into the precise nanoscale environment of interest, where off-targets are minimized and specificity reaches newheights.
Together: Discovery and Precision, Unified
Together, Synlight-Rich™ and Synlight-Pure™ form a seamless continuum:
- Synlight-Rich™ reveals the landscape: a wide, unbiased view of what’s present.
- Synlight-Pure™ defines the neighborhood: the local molecular architecture around a specific target.
This dual system enables researchers to transition seamlessly from broad proteomic exploration to focused mechanistic insights—all within the same platform and analytical workflow.
Redefining Cellular and Translational Insight at the Nanoscale
Whether probing synaptic signaling in neurons, trafficking defects in cancer models, or immune–tumor interfaces in tissue, precision dictates revelation. The ability to define proteomes at the 25-nm scale transforms how we understand cellular networks, gradients, and nanoscale assemblies.
Syncell’s Microscoop® platform brings this capability to researchers across cell biology, neurobiology, oncology, and translational proteomics. By merging optical precision with unbiased LC–MS discovery, Microscoop links molecular identity with biological functionunlocking the spatial logic of protein expression.
A New Paradigm for Discovery
Proteomics at the nanoscopic scale doesn’t just precisely locate proteins. It is a paradigm shift for spatial proteomics. It reshapes our understanding of biology. In cells or tissues, this approach allows scientists to ask and answer the most precise questions:
- What defines this functional niche?
- Which proteins assemble or disperse here under stimulation or disease?
- How does therapy rewire these nanoscale networks?
It’s about sharper insight. At the intersection of cell biology and proteomics, 25-nm range discovery is redefining how we uncover new drug targets, diagnostic biomarkers, and the molecular underpinnings of health and disease.
